Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV

Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

Gilead Sciences CEO Daniel O'Day on HIV prevention injection approval

Gilead CEO on funding for new HIV prevention medicine

Daniel O’Day of Gilead Sciences, Inc. on COVID-19 Efforts

Gilead Sciences CEO Daniel O'Day Remarks at 2019 World AIDS Day Observances

Daniel O'Day - Can't Sleep